Most over-the-counter cold medicines do not shorten the duration of a cold, and a handful of them carry mechanisms that could, in theory, nudge the illness to last slightly longer. The concern is not that a dose of acetaminophen or a squirt of nasal spray will add a week to your misery. It is subtler than that: fever reducers may blunt your immune response just enough to slow viral clearance, decongestant sprays can cause rebound congestion that mimics a cold dragging on, and cough suppressants perform barely better than a sugar pill in trials. The picture gets more interesting when you look at what the science actually shows for each class of medicine people reach for.
Fever Reducers and the Immune Trade-Off
Fever is not a malfunction. It is your immune system deliberately raising the thermostat to create an environment less hospitable to viruses and more conducive to immune cell activity. When you take a fever reducer like acetaminophen or ibuprofen, you feel better, but you are also dialing down one of the body’s primary defensive responses. The question researchers have asked is whether that trade-off matters in practice.
In a controlled study where volunteers were deliberately infected with rhinovirus, researchers found a trend toward longer viral shedding in people who took aspirin or acetaminophen compared to those who took a placebo, though the difference did not reach statistical significance.1The Journal of Infectious Diseases. Adverse Effects of Aspirin, Acetaminophen, and Ibuprofen on Immune Function, Viral Shedding, and Clinical Status in Rhinovirus-Infected Volunteers That same study found that both aspirin and acetaminophen suppressed the antibody response to the virus. A broader review of the literature confirms the concern: when antipyretics are given alongside vaccines, several large trials have reported reduced antibody levels, and the mechanism involves an enzyme called cyclooxygenase-2, which antibody-producing cells rely on and which these drugs inhibit.2Evolution, Medicine, and Public Health. Let fever do its job: The meaning of fever in the pandemic era
So the honest answer is that fever reducers probably do not add days to your cold in any dramatic way, but the biological plausibility for a modest delay is real. If your fever is mild and tolerable, letting it run may give your immune system a slight edge. If it is making you genuinely miserable or you cannot sleep, treating it is reasonable. The concern is more relevant for people who reflexively take acetaminophen at the first sign of any temperature elevation.
Decongestants Feel Like They Help, Then Sometimes Make Things Worse
Nasal decongestants, both the oral kind (like pseudoephedrine) and the spray kind (like oxymetazoline), are among the most satisfying cold medicines to use because they provide quick, noticeable relief. Evidence shows that they reduce nasal congestion over a window of roughly three to ten hours, but the data on whether they help beyond that short window is unclear.3BMJ Clinical Evidence. Common cold They do not kill the virus, shorten the infection, or do anything to the underlying disease. They shrink swollen blood vessels in your nasal passages so you can breathe.
The problem arrives when people use nasal spray decongestants for more than a few days. Chronic use leads to something called rebound congestion: the nasal passages swell up worse than before once the spray wears off, creating a cycle where you need the spray just to get back to baseline.4American Journal of Respiratory and Critical Care Medicine. Fluticasone Reverses Oxymetazoline-induced Tachyphylaxis of Response and Rebound Congestion The mechanism involves the receptors in nasal blood vessels becoming desensitized and downregulated after repeated stimulation, so the body’s own ability to regulate nasal blood flow is impaired.5European Annals of Otorhinolaryngology, Head and Neck Diseases. Rebound congestion and rhinitis medicamentosa: Nasal decongestants in clinical practice. Critical review of the literature by a medical panel This does not technically prolong the cold itself, but it prolongs congestion symptoms in a way that is indistinguishable from the cold dragging on. If you have ever felt like a cold “kept coming back” after using Afrin for a week, rebound congestion is the likely culprit.
The practical rule is simple: nasal spray decongestants for no more than three consecutive days. Oral decongestants carry less rebound risk but come with their own issues, including elevated blood pressure and insomnia, and still do nothing to shorten the infection.
Antihistamines Do Very Little for Colds
A lot of people take antihistamines for colds because their symptoms (runny nose, sneezing, watery eyes) feel like allergies. But the common cold is driven by viral inflammation, not histamine release, so antihistamines are working on the wrong mechanism. A Cochrane systematic review of the evidence found that antihistamines have a limited beneficial effect on overall symptom severity during the first two days of treatment, but no benefit in the mid to long term. There was no clinically meaningful effect on nasal congestion, runny nose, or sneezing.6PubMed Central. Antihistamines for the common cold
Antihistamines are unlikely to make your cold last longer. They are also unlikely to help it resolve faster. Their primary contribution is mild sedation (in the case of older antihistamines like diphenhydramine), which may help you sleep, and there is real value in that. But if you are taking them expecting to shorten the cold or clear your sinuses, the evidence does not support that expectation.
Cough Suppressants Barely Outperform Placebo
Cough is the single most common symptom of the common cold, and it is the one that drives the most over-the-counter purchases. Dextromethorphan (the “DM” in many cold products) and codeine are the two most studied cough suppressants for acute upper respiratory infections. Both perform poorly. A meta-analysis of five studies found that these drugs were only marginally better than placebo, and individual studies reported that codeine was no more effective than placebo either as a single dose or as a full daily regimen. A single 30-milligram dose of dextromethorphan showed very little if any support for clinically meaningful cough reduction.7PubMed Central. Cough management: a practical approach
There is a reasonable biological argument that suppressing cough could slow recovery. Cough exists to clear mucus and trapped viral particles from the airways. Preventing that clearance could, in theory, prolong the presence of the virus. In practice, though, the drugs are so weak that any such effect is probably negligible. The more honest concern is simply waste: you are spending money on something that is not doing what the box claims.
The Things That Might Actually Shorten a Cold
If most conventional cold medicines are symptom masks that do not change the timeline of the illness, is there anything that does? The evidence is stronger than you might expect for a couple of supplements, though it comes with significant caveats.
Zinc
Zinc lozenges are one of the better-supported interventions for actually reducing how long a cold lasts. In a randomized trial using zinc gluconate lozenges, the median time to complete symptom resolution was about four and a half days in the zinc group compared to about seven and a half days for placebo.8PubMed. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study A separate trial using zinc acetate lozenges found a similar pattern: about four days of symptoms versus about five days with placebo.9Current Therapeutic Research. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects It should be noted that a broader clinical evidence review was more cautious, stating that we do not know for certain whether zinc gel or lozenges reduce the duration of cold symptoms.10BMJ Clinical Evidence. Common cold
The catch is that zinc lozenges need to be started within the first 24 hours of symptoms to show benefit, they have to be taken frequently throughout the day, and they taste terrible. Many people also report nausea. The nasal zinc gels that were once popular were pulled from shelves after reports of permanent loss of smell, so stick with lozenges or oral forms if you try zinc.
Vitamin C
Vitamin C has been debated for decades. The evidence suggests it does something, but not as much as the popular imagination assumes. A meta-analysis found that vitamin C had a significant effect on the duration of severe cold symptoms but no meaningful effect on mild symptoms.11PubMed Central. Vitamin C reduces the severity of common colds: a meta-analysis An earlier double-blind trial found that people taking vitamin C experienced roughly 30 percent fewer total days of disability (days confined to the house or off work) compared to placebo, a statistically significant difference, even though the reduction in number of colds and total sick days was smaller and not statistically significant.12PubMed Central. Vitamin C and the common cold: a double-blind trial A re-analysis of earlier data also argued that therapeutic doses taken during a cold episode may be as effective as regular supplementation, with evidence of a dose-dependent relationship up to large daily doses.13PubMed. Vitamin C, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results
The practical takeaway is that vitamin C probably will not prevent you from catching a cold, but it might take the edge off the worst days of one, particularly if taken at higher doses once symptoms begin. It is cheap, very safe in typical supplemental doses, and one of the few interventions where the risk-benefit math clearly favors trying it.
Echinacea and the Limits of Herbal Evidence
Echinacea is one of the most popular herbal remedies for colds worldwide, and the evidence is genuinely mixed. A Cochrane review of the available trials concluded that echinacea products have not been shown to provide clear benefits for treating colds, though individual prevention trials consistently showed positive trends that did not reach statistical significance.14PubMed Central. Echinacea for preventing and treating the common cold Part of the problem is that “echinacea” is not one product. Different species, different plant parts, and different extraction methods may produce very different results.
One large randomized trial using a specific preparation (Echinaforce, made from Echinacea purpurea) did show significant results: about 26 percent fewer total episode days and a 59 percent reduction in recurring infections compared to placebo. That trial also found that echinacea appeared to be especially effective against enveloped viruses, including coronaviruses and influenza, with about half the number of detected infections in the treatment group.15PubMed Central. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial Those are promising numbers, but they come from a single trial with one specific product, and the broader literature has not reliably replicated them across different preparations.
If you find that echinacea seems to help you, the safety profile is generally favorable and there is no reason to stop. But the evidence is not strong enough to recommend it broadly the way you might recommend zinc.
The Surprisingly Powerful Role of Belief
One of the most striking findings in cold research has nothing to do with pharmacology. In a randomized controlled trial, participants who believed echinacea was effective and received pills (regardless of whether those pills actually contained echinacea) had illnesses that were about two and a half days shorter and roughly a quarter less severe than those who received no pills at all.16PubMed Central. Placebo effects and the common cold: a randomized controlled trial The drug itself did not produce those results. Belief did.
This finding complicates the entire conversation about cold medicines. If you genuinely believe that your favorite cold remedy works, that belief itself may produce measurable improvements in how long you are sick and how bad you feel. This is not imaginary. Placebo effects in upper respiratory infections show up in objective measures like illness duration, not just subjective symptom scores. It also means that telling someone their cold remedy is useless might, paradoxically, make it more useless. The researchers behind the trial suggested that beliefs and feelings about treatments should perhaps be taken into consideration when making medical decisions, a statement that sounds obvious but runs counter to the usual evidence-based instinct to dismiss anything that fails to beat placebo in a trial.
Why Cold Medicines for Children Deserve Special Caution
Everything discussed above applies mainly to adults. For children, the stakes around cold medicines are different and the evidence is thinner. Cough and cold medications are not appropriate for all age groups and can cause serious adverse effects, including death, when used incorrectly. The data on safety and effectiveness in children younger than six is lacking, and the FDA does not recommend cough and cold products containing antihistamines or decongestants for children under two.17PubMed Central. The Use and Safety of Cough and Cold Medications in the Pediatric Population
The risk in young children is not really about prolonging the cold. It is about overdose, respiratory depression, and cardiac effects from drugs whose dosing in small bodies has never been properly established. Many pediatricians now advise against any OTC cold medicines for children under six, recommending instead saline drops, honey (for children over one year), fluids, and rest. If your child has a cold and you are tempted to reach for a multi-symptom product, the safest answer is usually to treat the specific symptom that is most disruptive (typically congestion or sleep difficulty) with a single-ingredient approach rather than a cocktail.
Multi-Ingredient Products and the Kitchen-Sink Problem
Walk down the cold-medicine aisle and the products that dominate the shelf are combination formulas: a decongestant plus an antihistamine plus a cough suppressant plus a pain reliever. The appeal is obvious. You feel terrible in multiple ways, so why not hit all the symptoms at once?
The problem is that each added ingredient brings its own side effects without necessarily adding meaningful benefit. As reviewed above, antihistamines barely help cold symptoms, cough suppressants are marginally better than nothing, and fever reducers may mildly impair your immune response. Combining them does not produce synergy; it produces more side effects. You get the drowsiness of the antihistamine, the jitteriness of the decongestant, the potential immune suppression from the acetaminophen, and the liver burden of metabolizing multiple drugs simultaneously. The research community has noted that billions of dollars are spent annually on these multi-symptom products, and the evidence supporting their superiority over single-ingredient treatments is limited.18Springer Link. Treatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy–A Pro/Con Debate
A better approach, if you are going to use OTC medicines at all, is to identify the one or two symptoms that are actually bothering you most and treat those specifically. If congestion is the main problem, a single-ingredient decongestant for a day or two makes sense. If a fever is keeping you up at night, a dose of ibuprofen is reasonable. But the all-in-one nighttime formula with five active ingredients is usually overkill, and the cumulative side-effect burden is real.
What Your Nasal Passages Are Doing While You Medicate Them
Your nose is not just a passive air tube. It hosts a resident community of bacteria that directly influences your local immune defenses and the integrity of the nasal lining.19PubMed Central. Determinants of the Nasal Microbiome: Pilot Study of Effects of Intranasal Medication Use When you spray decongestants, antihistamines, or corticosteroids into your nose repeatedly, you are altering the environment those microbes live in. Early research suggests that intranasal medication use can shift the composition of the nasal microbiome, though the clinical significance of those shifts during a short cold is not yet clear.
This is one of those areas where the science is still catching up to the question. It is plausible that heavy nasal medication use during a cold could disrupt the microbial ecosystem that normally helps defend against secondary infections. Whether that disruption actually extends illness or increases the risk of a bacterial sinus infection landing on top of the viral cold is something researchers are still working out. In the meantime, it is another reason to use nasal medications judiciously rather than as a reflexive daily habit throughout a cold.
How Fever Reducers Might Affect Broader Immune Memory
Beyond the acute cold, there is an emerging question about whether suppressing fever during infections could affect the quality of the immune memory you build. The enzyme that fever reducers inhibit, cyclooxygenase-2, is actively used by B cells during antibody production. Nonsteroidal anti-inflammatory drugs have been shown to inhibit humoral immunity (the antibody-producing arm) while potentially augmenting cell-mediated immunity (the arm that kills infected cells directly).2Evolution, Medicine, and Public Health. Let fever do its job: The meaning of fever in the pandemic era The practical consequence is speculative but worth noting: if you aggressively suppress every fever from every cold, you might be building a slightly weaker library of antibodies against the viruses you encounter. Over a lifetime of respiratory infections, that could mean marginally less protection against reinfection with the same or similar strains.
This is a frontier of research, not a settled conclusion. Nobody has demonstrated that taking acetaminophen during a cold in 2024 will make you catch more colds in 2025. But the direction of the evidence has pushed some researchers and clinicians toward a more tolerant attitude about mild fevers during self-limiting infections: if you can ride it out, you might be better served by doing so.